PERUSE

PERUSE

ROCHE PERUSE A Multi-Center,Open Label, Single-Arm study of Pertuzumab in combination with Trastuzumab and a Taxane in first line treatment of Patients with HER2-Positive Metastatic or Advanced Breast Cancer.